Evidence map›Paper›PMID 35968591›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2022

[Prognostic analysis and predictive model construction of bleeding events in allogeneic hematopoietic stem cell transplant patients].

J Q Qi, T You, H Wang, W Han, Y Fan, J Chen, D P Wu, Y Han

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

J Q QiThe First Affiliated Hospital of Suzhou University, Jiangsu Institute of Hematology, National Center for Hematology and Clinical Research, Hematopoietic Stem Cell Transplantation Institute of Soochow University, Hematology Collaborative Innovation Center, Suzhou 215006, China.
T YouThe First Affiliated Hospital of Suzhou University, Jiangsu Institute of Hematology, National Center for Hematology and Clinical Research, Hematopoietic Stem Cell Transplantation Institute of Soochow University, Hematology Collaborative Innovation Center, Suzhou 215006, China.
H WangThe First Affiliated Hospital of Suzhou University, Jiangsu Institute of Hematology, National Center for Hematology and Clinical Research, Hematopoietic Stem Cell Transplantation Institute of Soochow University, Hematology Collaborative Innovation Center, Suzhou 215006, China.
W HanThe First Affiliated Hospital of Suzhou University, Jiangsu Institute of Hematology, National Center for Hematology and Clinical Research, Hematopoietic Stem Cell Transplantation Institute of Soochow University, Hematology Collaborative Innovation Center, Suzhou 215006, China.
Y FanThe First Affiliated Hospital of Suzhou University, Jiangsu Institute of Hematology, National Center for Hematology and Clinical Research, Hematopoietic Stem Cell Transplantation Institute of Soochow University, Hematology Collaborative Innovation Center, Suzhou 215006, China.
J ChenThe First Affiliated Hospital of Suzhou University, Jiangsu Institute of Hematology, National Center for Hematology and Clinical Research, Hematopoietic Stem Cell Transplantation Institute of Soochow University, Hematology Collaborative Innovation Center, Suzhou 215006, China.
D P WuThe First Affiliated Hospital of Suzhou University, Jiangsu Institute of Hematology, National Center for Hematology and Clinical Research, Hematopoietic Stem Cell Transplantation Institute of Soochow University, Hematology Collaborative Innovation Center, Suzhou 215006, China.
Y HanThe First Affiliated Hospital of Suzhou University, Jiangsu Institute of Hematology, National Center for Hematology and Clinical Research, Hematopoietic Stem Cell Transplantation Institute of Soochow University, Hematology Collaborative Innovation Center, Suzhou 215006, China.
Soochow University · CN

Funding

National Natural Science Foundation of China 81873432, 82070143
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationHemorrhageHumansPrognosisRetrospective StudiesTransplantation, HomologousAllogeneic hematopoietic stem cell transplantationForecasting modelHemorrhage

Identifiers

PMID35968591
PMCPMC9800225
OpenAlexW4301755219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.